JP2021523129A5 - - Google Patents
Info
- Publication number
- JP2021523129A5 JP2021523129A5 JP2020562156A JP2020562156A JP2021523129A5 JP 2021523129 A5 JP2021523129 A5 JP 2021523129A5 JP 2020562156 A JP2020562156 A JP 2020562156A JP 2020562156 A JP2020562156 A JP 2020562156A JP 2021523129 A5 JP2021523129 A5 JP 2021523129A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- combination
- hcv
- subject
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862669007P | 2018-05-09 | 2018-05-09 | |
| US62/669,007 | 2018-05-09 | ||
| PCT/US2019/031459 WO2019217643A1 (en) | 2018-05-09 | 2019-05-09 | Combination therapy for treatment of hcv |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021523129A JP2021523129A (ja) | 2021-09-02 |
| JP2021523129A5 true JP2021523129A5 (https=) | 2022-05-17 |
| JPWO2019217643A5 JPWO2019217643A5 (https=) | 2022-05-17 |
| JP7381493B2 JP7381493B2 (ja) | 2023-11-15 |
Family
ID=66641500
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020562156A Active JP7381493B2 (ja) | 2018-05-09 | 2019-05-09 | Ｈｃｖを治療するための併用療法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11752166B2 (https=) |
| EP (1) | EP3790542B1 (https=) |
| JP (1) | JP7381493B2 (https=) |
| KR (1) | KR20210018806A (https=) |
| CN (1) | CN112203652A (https=) |
| AU (1) | AU2019265740A1 (https=) |
| CA (1) | CA3096916A1 (https=) |
| MX (1) | MX2020011912A (https=) |
| TW (1) | TWI833753B (https=) |
| WO (1) | WO2019217643A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022015982A1 (en) * | 2020-07-17 | 2022-01-20 | The Regents Of The University Of California | Compositions and methods for treating viral infections |
| KR20240022574A (ko) | 2021-06-17 | 2024-02-20 | 아테아 파마슈티컬즈, 인크. | 유리한 항-hcv 조합 요법 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6887877B2 (en) | 2001-06-11 | 2005-05-03 | Virochem Pharma Inc. | Compounds and methods for the treatment or prevention of Flavivirus infections |
| CN101624391A (zh) | 2001-06-11 | 2010-01-13 | 病毒化学医药公司 | 用作黄病毒感染抗病毒剂的噻吩衍生物 |
| EP1321463B1 (en) | 2001-12-21 | 2007-08-08 | Virochem Pharma Inc. | Thiazole derivatives and their use for the treatment or prevention of Flavivirus infections |
| JP4926403B2 (ja) | 2002-12-10 | 2012-05-09 | ヴァイロケム ファーマ インコーポレイテッド | フラビウイルス感染の処置もしくは予防のための化合物および方法 |
| US7402608B2 (en) | 2002-12-10 | 2008-07-22 | Virochem Pharma Inc. | Compounds and methods for the treatment or prevention of Flavivirus infections |
| AU2003291886A1 (en) | 2002-12-10 | 2004-06-30 | Virochem Pharma Inc. | Thiophenederivatives for the treatment of flavivirus infections |
| DE102004061746A1 (de) | 2004-12-22 | 2006-07-06 | Bayer Healthcare Ag | Alkinyl-substituierte Thiophene |
| BRPI0610283A2 (pt) | 2005-05-13 | 2010-10-19 | Virochem Pharma Inc | composto, uso do mesmo na preparação de um medicamento para o tratamento ou prevenção de uma infecção por vìrus de hepatite c, composição farmacêutica e combinação farmacêutica |
| WO2008017688A1 (en) | 2006-08-11 | 2008-02-14 | Smithkline Beecham Corporation | 2-carboxy thiophene derivatives as anti-viral agents |
| WO2008043791A2 (en) | 2006-10-13 | 2008-04-17 | Smithkline Beecham Corporation | Thiophene derivatives for treating hepatitis c |
| CA2670260A1 (en) | 2006-11-15 | 2008-05-22 | Virochem Pharma Inc. | Thiophene analogues for the treatment or prevention of flavivirus infections |
| EP2086966B1 (en) | 2006-11-17 | 2011-09-14 | GlaxoSmithKline LLC | 2-carboxy thiophene derivatives as anti viral agents |
| GB0707092D0 (en) | 2007-04-12 | 2007-05-23 | Smithkline Beecham Corp | Compounds |
| GB0712393D0 (en) | 2007-06-26 | 2007-08-01 | Smithkline Beecham Corp | Compounds |
| BR112015009636A8 (pt) | 2012-10-29 | 2018-04-17 | Cocrystal Pharma Inc | composto, métodos para o tratamento de um hospedeiro infectado, métodos para a prevenção de uma infecção, métodos para a redução da atividade biológica de uma infecção e uso de um composto |
| JP2017513852A (ja) * | 2014-04-15 | 2017-06-01 | コクリスタル ファーマ，インコーポレイテッド | Ｃ型肝炎ウイルスの強力及び選択的な阻害剤 |
| TWI731854B (zh) * | 2015-03-23 | 2021-07-01 | 美商共結晶製藥公司 | Ｃ型肝炎病毒聚合酶之抑制劑 |
| US9937160B2 (en) * | 2015-07-16 | 2018-04-10 | Cipla (UK) Limited | Thienopyridine derivative for the treatment of hepatitis C infections |
-
2019
- 2019-05-09 MX MX2020011912A patent/MX2020011912A/es unknown
- 2019-05-09 WO PCT/US2019/031459 patent/WO2019217643A1/en not_active Ceased
- 2019-05-09 AU AU2019265740A patent/AU2019265740A1/en not_active Abandoned
- 2019-05-09 EP EP19726259.5A patent/EP3790542B1/en active Active
- 2019-05-09 TW TW108116038A patent/TWI833753B/zh active
- 2019-05-09 CA CA3096916A patent/CA3096916A1/en active Pending
- 2019-05-09 JP JP2020562156A patent/JP7381493B2/ja active Active
- 2019-05-09 US US17/047,209 patent/US11752166B2/en active Active
- 2019-05-09 CN CN201980030086.3A patent/CN112203652A/zh active Pending
- 2019-05-09 KR KR1020207033655A patent/KR20210018806A/ko not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021521118A5 (https=) | ||
| JP2004509061A5 (https=) | ||
| JP2008518943A5 (https=) | ||
| RU2011127080A (ru) | Производное циклоспорина для применения в лечении заражения вирусом гепатита с и вич | |
| JP2014530874A5 (https=) | ||
| JP2013529627A5 (https=) | ||
| RU2007105354A (ru) | Применение комбинации циклоспорина и пэгилированного интерферона для лечения гепатита с (hcv) | |
| RU2329050C2 (ru) | Комбинация ингибиторов цитохром-р450-зависимых протеаз | |
| WO1995003056A1 (en) | Hepatitis c virus proliferation inhibitor | |
| JP2013522302A5 (https=) | ||
| JP2010503396A5 (https=) | ||
| JP2011528713A5 (https=) | ||
| CA2490200A1 (en) | 2' and 3'-nucleoside prodrugs for treating flaviviridae infections | |
| JP2017514911A5 (https=) | ||
| HRP20171898T1 (hr) | Kombinacija direktno djelujućih antivirusnih sredstava i ribavirina za liječenje hcv bolesnika | |
| Sun et al. | Recent progress in potential anti-hepatitis B virus agents: structural and pharmacological perspectives | |
| JP2002528502A5 (https=) | ||
| JP2018532797A5 (https=) | ||
| CN102083435A (zh) | 特拉匹韦给药方案 | |
| JP2021523129A5 (https=) | ||
| NZ598465A (en) | Dosage regimens for hcv combination therapy comprising bi201335, interferon alpha and ribavirin | |
| JPWO2019200005A5 (https=) | ||
| JP2023518390A (ja) | ウイルス感染症の治療若しくは予防又はウイルス感染症の発生を制限するための方法及び組成物 | |
| JPWO2019217643A5 (https=) | ||
| JP2021522802A5 (https=) |